IP Library › Granted Patent US 11,174,288
Granted Patent B2
US 11,174,288 · App. 15/832,194 · Granted Nov 16, 2021

Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria

Inventors: Run Chang (Brighton, MA); Keerthana Subramanian (Boston, MA); Mian Wang (Malden, MA); Thomas J. Webster (Barrington, RI)
Assignee: Northeastern University
C07K7/08A61P31/04C07H5/06C07H5/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,174,288
App. No.
15/832,194
Granted
Nov 16, 2021
Kind
B2
Abstract

Disclosed are peptides comprising an amphiphilic backbone and a cationic heparin-binding motif peptide. The peptides can be used in methods of antimicrobial treatment.

Claims (31)

1. A polypeptide, comprising an amphiphilic backbone, and a cationic heparin-binding motif peptide, wherein the polypeptide is represented by:

R 1 −y 1 −y 2

wherein

R 1 -y 1 is the amphiphilic backbone;

y 2 is the cationic heparin-binding motif peptide;

R 1 is an alkyl group or an alkenyl group; and

y 1 has the sequence V 4 K 4 (SEQ ID NO: 1) or V 4 K 4 G (SEQ ID NO: 4).

2. The polypeptide of claim 1 , wherein R 1 is a C 10 -C 22 alkyl group or a C 10 -C 22 alkenyl group.

3. The polypeptide of claim 1 having the sequence C 16 alkyl-V 4 K 4 G(AKKARA) 2 (SEQ ID NO: 7).

4. The polypeptide of claim 1 , wherein y 2 has the sequence (SEQ ID NO: 5):

−(WZZWZW) m

wherein

W is A or G;

Z is K or R; and

m is 2, 3, 4, 5, 6, 7, 8, 9, or 10.

5. The polypeptide of claim 4 , wherein R 1 is a C 10 -C 22 alkyl group or a C 10 -C 22 alkenyl group.

6. The polypeptide of claim 4 , wherein W is A.

7. The polypeptide of claim 6 , wherein R 1 is a C 10 -C 22 alkyl group or a C 10 -C 22 alkenyl group.

8. The polypeptide of claim 4 , wherein Z is K.

9. The polypeptide of claim 8 , wherein R 1 is a C 10 -C 22 alkyl group or a C 10 -C 22 alkenyl group.

10. The polypeptide of claim 4 , wherein y 2 has the sequence −(AKKARA) m (SEQ ID NO: 6).

11. The polypeptide of claim 10 , wherein R 1 is a C 10 -C 22 alkyl group or a C 10 -C 22 alkenyl group.

12. A method of antibacterial treatment, comprising:

providing a sample comprising bacteria;

adding to the sample a plurality of polypeptides of claim 1 , thereby killing or inhibiting the growth of at least a portion of the bacteria in the sample.

13. A method of preventing or suppressing bacterial growth on a surface, comprising:

applying to the surface a plurality of polypeptides of claim 1 , thereby preventing or suppressing bacterial growth on the surface.

14. A method of preparing self-assembled nanorods comprising the steps of:

dissolving a plurality of lyophilized polypeptides of claim 1 in a solvent to form a mixture;

mixing the mixture; and

storing the mixture to allow for supramolecular self-assembly, thereby preparing self-assembled nanorods.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2017
From: CHANG, RUN; SUBRAMANIAN, KEERTHANA; WANG, MIAN; WEBSTER, THOMAS
To: NORTHEASTERN UNIVERSITY
Reel/Frame 044347/0882 →
Continuity (2)
Provisional Application 62430906 · Dec 6, 2016
Related Publication 20180179255A1 · Jun 28, 2018
Cited By (1)
US 12,319,752